Track the CalciMedica, Inc. /DE/ stock price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €10.9m. The latest transaction was filed on 22 March 2023 (Attribution). Among the most active insiders: Roberts Eric W. The full history is free.
Analysts rate CalciMedica, Inc. /DE/ Strong Buy (bullish), based on 2 analysts. Average price target: US$10.50.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
CalciMedica, Inc. es una empresa de biotecnología centrada en el desarrollo de tratamientos para enfermedades relacionadas con la regulación del calcio. Cotiza en NASDAQ bajo el ticker XNAS.